Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Daily Women's Health Policy Report Summarizes Studies Examining Ovarian Cancer
The following summarizes recent research related to ovarian cancer.~ Early periods linked to lower survival: Women who start menstruating at an early age or experience more menstrual cycles over their lifetimes appear to have a lower chance of surviving ovarian cancer, according to a study published this month in the journal Cancer Epidemiology, Biomarkers, and Prevention, Reuters reports. For the study, researcher Cheryl Robbins and colleagues analyzed the medical data of 410 ovarian cancer patients who participated in the Cancer and Steroid Hormone study between 1980 and 1982. The analysis found that the women who had their first period before age 12 had a 51% greater risk of dying than the women who began menstruating at age 14 or older. The women who had the highest number of lifetime menstrual cycles had a 67% greater risk of dying during follow-up than the women with the lowest number of cycles (Reuters, 7/24).~ Lung cancer risk higher for women after hysterectomy with ovary removal: Women who have had hysterectomies in which their uterus and both ovaries are removed to prevent ovarian cancer appear to have a higher risk for developing lung cancer, according to researchers at the University of Montreal, the New York Times reports. The researchers discovered the connection while looking for links between lung cancer and hormones for a study published in May in the International Journal of Cancer. Although they did not find a relationship between lung cancer risk and hormonal factors such as menstruation patterns, child-bearing or breastfeeding, the researchers found that women who had medically induced menopause had 1.92 times greater risk of developing lung cancer than women who had natural menopause (Caryn Rabin, New York Times, 7/24).~ Small tumors present for years before detection: Minute-sized ovarian tumors form and remain in the Fallopian tubes for an average of four years before they grow large enough to be detected, which might suggest why ovarian cancer frequently is diagnosed in its later stages, according to a study published in the journal PLoS Medicine, Reuters reports. For the study, lead researcher Patrick Brown of Stanford University and the Howard Hughes Medical Institute and colleagues analyzed the tumors of women whose Fallopian tubes and ovaries were removed because they had family histories of and genetic risk for ovarian cancer. They found small tumors -- most less than three millimeters in diameter -- that previously had not been detected in the women. In a statement, Brown said, "There is a long window of opportunity for potentially lifesaving early detection of this disease, but the tumor spreads while it is still much too small to be detected by any of the tests that have been developed or proposed to date." According to Reuters, blood tests for the compound called CA-125 may help guide therapy but do not indicate whether a woman has a tumor (Reuters, 7/28).
generic viagra online
Provectus Pharmaceuticals To Offer Compassionate Use Of PV-10 For Non-Visceral Indications In Cancer Patients
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients.
News of the day
Gene Therapy Could Expand Stem Cells' Promise
Once placed into a patient"s body, stem cells intended to treat or cure a disease could end up wreaking havoc simply because they are no longer under the control of the clinician.
Diagnostics

Rep. Stupak Signals Willingness To Compromise On Abortion Coverage In Health Reform Legislation

Rep. Bart Stupak (D-Mich.) on Monday said that he and House Energy and Commerce Committee Chair Henry Waxman (D-Calif.) are negotiating to resolve the concerns of antiabortion-rights Democrats who want to exclude abortion coverage from the House health reform bill (HR 3200), Dow Jones reports. Stupak said that the compromise would affect how state abortion laws are handled under the bill (Yoest, Dow Jones, 7/20.). According to the AP/Atlanta Journal-Constitution, Stupak did not give details on the negotiations, and aides said that no final deal has been reached (Werner, AP/Atlanta Journal-Constitution, 7/21).Stupak said that he and Waxman"s staff discussed the compromise over the weekend. According to Stupak, a compromise could be voted on this week as an amendment during the committee"s markup of the bill. According to Dow Jones, Stupak holds a key vote on the health bill, which faces opposition from some other conservative Democrats on the panel over costs. His comments on Monday suggest "an easing of tensions" between antiabortion-right Democrats and supporters of the bill, Dow Jones reports. Stupak and 19 other House Democrats last week sent a letter to party leaders stating that they "cannot support a health care reform proposal unless it explicitly excludes abortion from the scope of any government-defined or subsidized health plan." They also stated that they want to ensure that a health benefits advisory council created under the bill "cannot recommend abortion services be included under covered benefits or as part of a benefits package." The advisory council would make recommendations to the HHS secretary, who would make final determinations on what public and private plans would be required to cover in a health insurance exchange. Stupak said that the two sides are "working in good faith" and that other members of the committee should not push their own abortion-related amendments (Dow Jones, 7/20). On Monday, committee voted 20-35 to reject an amendment, offered by Rep. Nathan Deal (R-Ga.), that would have eliminated a provision requiring states to adhere to minimum benefits requirements that employer-sponsored insurance must include. Deal said that states could be required to cover abortion or "out of mainstream" services. Stupak responded, "I hope we"re not going to start using reproductive rights as a red herring on every amendment that comes up." Panel Approves Sex Education AmendmentThe panel voted 33-23 to approve an amendment that would authorize $250 million through 2014 for "evidence-based" sex education programs for teenagers. Rep. Lois Capps (D-Calif.), who offered the amendment, said that abstinence-only programs would not be excluded if they are proven effective. Following debate on Capps" amendment, Rep. Lee Terry (R-Neb.) offered an amendment that would reauthorize the Title V abstinence-only sex education program. Committee Chair Henry Waxman (D-Calif.) said that Title V "has been a failure," adding that 25 states refused to accept the money through the program because it is ineffective. Terry"s amendment was rejected 26-29.The committee also voted 36-23 to adopt an amendment that would provide $150 million in grants through 2014 to state and local governments and not-for-profits for educating residents in "medically underserved" areas on various topics, including sexual behavior (Wayne, CQ Today, 7/21). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009